Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients

類似資料

• Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder
  著者:: Medhasi, Sadeep, 等
  出版事項: (2016)
• Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9‐Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders
  著者:: Vanwong, Natchaya, 等
  出版事項: (2016)
• Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors
  著者:: Vanwong, Natchaya, 等
  出版事項: (2020)
• CYP2D6 polymorphisms and their influence on risperidone treatment
  著者:: Puangpetch, Apichaya, 等
  出版事項: (2016)
• Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
  著者:: Hongkaew, Yaowaluck, 等
  出版事項: (2015)